Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. LMT
10. SBUX

Go back to Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c

Piper Jaffray Upgrades Achillion Pharmaceuticals (ACHN) to Overweight

August 11, 2014 7:02 AM EDT

Piper Jaffray upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Neutral to Overweight with a price target of $10.00 (from $5.00). Analyst Edward A. Tenthoff thinks potential suitors could emerge soon.

"Achillion ended 2Q:14 with cash of $131.5 million to advance its emerging HCV pipeline. Achillion... More

Wells Fargo Upgrades Achillion Pharmaceuticals (ACHN) to Outperform

August 11, 2014 6:19 AM EDT

Wells Fargo upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Market Perform to Outperform with a price target of $11-$13 (from $7-$8). Analyst Brian Abrahams is more confident as ACH-3422 progresses without incident, and he is optimistic on readouts for 3422 and 3102.

For an analyst ratings summary... More